Uromigos-Kidney Cancer

The UromigosThe Uromigos | January 23, 2023
A summary of the renal cancer session of the Conversations & Trending Topics in GU Cancers conference in the Canary Islands.
Listen Now
The UromigosThe Uromigos | January 3, 2023
Monty Pal, MD, FASCO, discusses his recent study on the use of novel CAR T-cell therapy for renal cell carcinoma.
The UromigosThe Uromigos | December 12, 2022
David McDermott, MD, debates the role of ipilimumab for clear cell renal cancer with Uromigos host Brian Rini, MD.
The UromigosThe Uromigos | December 5, 2022
Pavlos Msaouel chats with The Uromigos about his editorial on the results of the recent COSMIC-313 trial.
The UromigosThe Uromigos | November 28, 2022
The Uromigos chat with Dan Shapiro, Assistant Professor of Urologic Oncology, on his work in renal medullary carcinoma.
The UromigosThe Uromigos | November 14, 2022
The Uromigos chat with Scott M. Haake for the second episode of their Rising Star series and discuss his latest project.
The UromigosThe Uromigos | November 14, 2022
The Rising Star series starts with Renee Saliby, a postdoctoral GU oncology research fellow at Dana-Farber Cancer Institute.
The UromigosThe Uromigos | September 14, 2022
Toni Choueiri describes the COSMIC-313 trial on cabozantinib with nivolumab and ipilimumab in advanced or metastatic RCC.
The UromigosThe Uromigos | August 9, 2022
Bernard Escudier, MD, joins The Uromigos to talk about his career development and work in the field of kidney cancer.
The UromigosThe Uromigos | July 11, 2022
Kimryn Rathmell, MD, PhD, discusses highlights from the kidney cancer guidelines presented at the ASCO Annual Meeting.
The UromigosThe Uromigos | June 27, 2022
Darren Feldman describes different approaches to relapsed germ cell tumors and the TIGER study.
The UromigosThe Uromigos | May 2, 2022
David Braun gives an overview of the mechanisms of response to PD1 therapy in renal cancer.
The UromigosThe Uromigos | April 22, 2022
Michael Staehler gives an overview of the abstracts presented in the oral session from EIKCS 2022.
The UromigosThe Uromigos | March 21, 2022
Dr. David McDermott attempts to get his point across he discusses favorable risk clear cell renal cancer and its treatments.
The UromigosThe Uromigos | February 17, 2022
Dr. Laurence Albiges gives an overview of the new ESMO RCC guidelines, and Brian challenges her and Tom.
The UromigosThe Uromigos | January 24, 2022
Dr. David Cella unpacks the data across these studies and makes some conclusions.
GU Oncology Now EditorsThe Uromigos | December 28, 2021
Dr. David McDermott describes his clinical cancer research paper on treatment-free survival in kidney cancer.
The UromigosThe Uromigos | December 21, 2021
Chad Tang discusses his oncology paper recently published in Lancet.
The UromigosThe Uromigos | December 17, 2021
Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri.
The UromigosThe Uromigos | October 29, 2021
Dr. Mike Atkins discusses the role of CTLA4 inhibition in RCC.
Advertisement
Advertisement